These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 3907286

  • 1. One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis.
    Holmgren K, Andersson G, Fagrell B, Johnsson H, Ljungberg B, Nilsson E, Wilhelmsson S, Zetterquist S.
    Acta Med Scand; 1985; 218(3):279-84. PubMed ID: 3907286
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial.
    Campbell IA, Bentley DP, Prescott RJ, Routledge PA, Shetty HG, Williamson IJ.
    BMJ; 2007 Mar 31; 334(7595):674. PubMed ID: 17289685
    [Abstract] [Full Text] [Related]

  • 3. An audit of the clinical and sub-clinical changes in the first year following an acute deep vein thrombosis.
    O'Shaughnessy AM, Fitzgerald DE.
    Int Angiol; 2001 Jun 31; 20(2):141-7. PubMed ID: 11533522
    [Abstract] [Full Text] [Related]

  • 4. The duration of oral anticoagulation after deep vein thrombosis. A randomized study.
    Schulman S, Lockner D, Juhlin-Dannfelt A.
    Acta Med Scand; 1985 Jun 31; 217(5):547-52. PubMed ID: 3895828
    [Abstract] [Full Text] [Related]

  • 5. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S, Bielska-Falda H, Noszczyk W, Bielawiec M, Witkiewicz W, Filipecki S, Michalak J, Ciesielski L, Mackiewicz Z, Czestochowska E, Zawilska K, Cencora A.
    Thromb Haemost; 1999 Jan 31; 81(1):26-31. PubMed ID: 9974369
    [Abstract] [Full Text] [Related]

  • 6. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D, Díaz G, Marín E, Vidal R, Sueiro A, Yusen RD.
    Thromb Haemost; 2006 Mar 31; 95(3):562-6. PubMed ID: 16525588
    [Abstract] [Full Text] [Related]

  • 7. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis.
    Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, Nony P, Sanson C, Boissel JP, Investigators of the "Durée Optimale du Traitement AntiVitamines K" (DOTAVK) Study.
    Circulation; 2001 May 22; 103(20):2453-60. PubMed ID: 11369685
    [Abstract] [Full Text] [Related]

  • 8. Early follow-up and treatment recommendations for isolated calf deep venous thrombosis.
    Singh K, Yakoub D, Giangola P, DeCicca M, Patel CA, Marzouk F, Giangola G.
    J Vasc Surg; 2012 Jan 22; 55(1):136-40. PubMed ID: 21982332
    [Abstract] [Full Text] [Related]

  • 9. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
    Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A.
    Haematologica; 1997 Jan 22; 82(4):423-8. PubMed ID: 9299855
    [Abstract] [Full Text] [Related]

  • 10. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
    Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P.
    Thromb Haemost; 1995 Aug 22; 74(2):606-11. PubMed ID: 8584992
    [Abstract] [Full Text] [Related]

  • 11. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G, Nicolaides AN, Cesarone MR, Laurora G, De Sanctis MT, Incandela L, Barsotti A, Corsi M, Vasdekis S, Christopoulos D, Lennox A, Malouf M.
    Angiology; 1999 Oct 22; 50(10):781-7. PubMed ID: 10535716
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
    Piazza G, Mani V, Goldhaber SZ, Grosso MA, Mercuri M, Lanz HJ, Schussler S, Hsu C, Chinigo A, Ritchie B, Nadar V, Cannon K, Pullman J, Concha M, Schul M, Fayad ZA, edoxaban Thrombus Reduction Imaging Study (eTRIS) Investigators.
    Vasc Med; 2016 Aug 22; 21(4):361-8. PubMed ID: 27165711
    [Abstract] [Full Text] [Related]

  • 13. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago.
    Ziegler S, Schillinger M, Maca TH, Minar E.
    Thromb Res; 2001 Jan 15; 101(2):23-33. PubMed ID: 11342203
    [Abstract] [Full Text] [Related]

  • 14. [Improving recanalization of deep veins and the "outcomes" of venous thromboembolic complications in prolonged therapy with enoxaparin].
    Vorob'eva NM, Panchenko EP, Dobrovol'skiĭ AB, Titaeva EV, Ermolina OV, Balakhonova TV, Kirienko AI.
    Angiol Sosud Khir; 2010 Jan 15; 17(1):87-94. PubMed ID: 21780625
    [Abstract] [Full Text] [Related]

  • 15. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators.
    Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, Moia M, Guazzaloca G, Bertoldi A, Tomasi C, Scannapieco G, Ageno W, Warfarin Optimal Duration Italian Trial Investigators.
    N Engl J Med; 2001 Jul 19; 345(3):165-9. PubMed ID: 11463010
    [Abstract] [Full Text] [Related]

  • 16. Evolution of deep venous thrombosis: a 2-year follow-up using duplex ultrasound scan and strain-gauge plethysmography.
    Haenen JH, Wollersheim H, Janssen MC, Van 't Hof MA, Steijlen PM, van Langen H, Skotnicki SH, Thien T.
    J Vasc Surg; 2001 Oct 19; 34(4):649-55. PubMed ID: 11668319
    [Abstract] [Full Text] [Related]

  • 17. Risk factors and coagulation parameters in relationship to phlebographic response and clinical outcome in the treatment of acute deep vein thrombosis.
    Breddin HK, Kadziola Z, Scully M, Nakov R, Misselwitz F, Kakkar VV.
    Thromb Haemost; 2003 Feb 19; 89(2):272-7. PubMed ID: 12574806
    [Abstract] [Full Text] [Related]

  • 18. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
    Venet C, Berger C, Tardy B, Viallon A, Decousus H, Bertrand JC.
    Presse Med; 2000 Jan 22; 29(2):68-75. PubMed ID: 10682030
    [Abstract] [Full Text] [Related]

  • 19. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study.
    Parisi R, Visonà A, Camporese G, Verlato F, Lessiani G, Antignani PL, Palareti G.
    Int Angiol; 2009 Feb 22; 28(1):68-72. PubMed ID: 19190559
    [Abstract] [Full Text] [Related]

  • 20. Short- and long-term results after thrombolytic treatment of deep venous thrombosis.
    Schweizer J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L, Graf A.
    J Am Coll Cardiol; 2000 Oct 22; 36(4):1336-43. PubMed ID: 11028492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.